Search results
Earnings call: SelectQuote sees growth in Medicare Advantage, raises outlook By Investing.com
Investing.com· 7 days agoSelectQuote, Inc. (SLQT) delivered a confident fiscal third-quarter earnings report, emphasizing...
(Toni says) Please simplify Medicare’s enrollment process
Cullman Times· 6 days agoToni: I need to make the right Medicare decision because I turn 65 in August and have not had a...
Analyst Report: Humana Inc.
Morningstar Research via Yahoo Finance· 2 days agoHumana is one of the largest private health insurers in the US with a focus on administering Medicare Advantage plans. The firm has built a niche specializing ...
Man vs. Machine: Federal Employees - Medicare and FEHB
TheStreet.com· 3 days agoMan vs. Machine: ChatGPT tackles FEHB plans & Medicare. Expert critique inside!
CVS Risks Losing 10% of Medicare Members in Push for Profits
Bloomberg· 3 days agoHave a confidential tip for our reporters? CVS Health Corp. may lose a big chunk of members in its...
Social Security or Medicare: Which Is in the Most Immediate Danger?
Motley Fool via Yahoo Finance· 5 days agoIt comes in two key forms: original Medicare ,which includes Parts A and B, typically with Part D...
HHS Final Section 1557 Nondiscrimination Regulations: Gender-Affirming Care and the Role of Carriers...
The National Law Review· 7 days agoIf Section 1557 applies to carriers and TPAs acting in an ASO capacity for self-funded group health...
Comment: Turning 65? Here’s what to know about Medicare | HeraldNet.com
Everett Herald· 2 days agoWhether this milestone means retirement or not, these individuals need to make important choices about their health care. For many Washington residents, the transition from an employer-sponsored ...
Blend Extra: Maximize Medicare, Cancer Insurance, and More!!
TMJ4 Milwaukee· 1 day agoWith access to dozens of insurance companies and their products, Sovereign Select custom fits your ...
Does Medicare Cover the RSV Vaccine?
US News Health· 3 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.